These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 25151571

  • 1. Cost-effectiveness of tolvaptan for euvolemic or hypervolemic hyponatremia.
    Lee MY, Kang HJ, Park SY, Kim HL, Han E, Lee EK.
    Clin Ther; 2014 Sep 01; 36(9):1183-94. PubMed ID: 25151571
    [Abstract] [Full Text] [Related]

  • 2. An economic analysis of tolvaptan compared with fluid restriction among hospitalized patients with hyponatremia.
    Ramamohan V, Mladsi D, Ronquest N, Kamat S, Boklage S.
    Hosp Pract (1995); 2017 Aug 01; 45(3):111-117. PubMed ID: 28449624
    [Abstract] [Full Text] [Related]

  • 3. Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review.
    Nemerovski C, Hutchinson DJ.
    Clin Ther; 2010 Jun 01; 32(6):1015-32. PubMed ID: 20637957
    [Abstract] [Full Text] [Related]

  • 4. Economic impact of tolvaptan treatment vs. fluid restriction based on real-world data among hospitalized patients with heart failure and hyponatremia.
    Dasta JF, Sundar S, Chase S, Lingohr-Smith M, Lin J.
    Hosp Pract (1995); 2018 Oct 01; 46(4):197-202. PubMed ID: 30045645
    [Abstract] [Full Text] [Related]

  • 5. Use of tolvaptan in patients hospitalized for worsening chronic heart failure with severe hyponatremia: The initial experience at a single-center in Turkey.
    Sağ S, Aydın Kaderli A, Yıldız A, Gül BC, Özdemir B, Baran İ, Güllülü S, Aydınlar A, Çavuşoğlu Y.
    Turk Kardiyol Dern Ars; 2017 Jul 01; 45(5):415-425. PubMed ID: 28694395
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden.
    Jamookeeah C, Robinson P, O'Reilly K, Lundberg J, Gisby M, Ländin M, Skov J, Trueman D.
    BMC Endocr Disord; 2016 May 16; 16(1):22. PubMed ID: 27184496
    [Abstract] [Full Text] [Related]

  • 7. Tolvaptan and Neurocognitive Function in Mild to Moderate Chronic Hyponatremia: A Randomized Trial (INSIGHT).
    Verbalis JG, Ellison H, Hobart M, Krasa H, Ouyang J, Czerwiec FS, Investigation of the Neurocognitive Impact of Sodium Improvement in Geriatric Hyponatremia: Efficacy and Safety of Tolvaptan (INSIGHT) Investigators.
    Am J Kidney Dis; 2016 Jun 16; 67(6):893-901. PubMed ID: 26874645
    [Abstract] [Full Text] [Related]

  • 8. Update on tolvaptan for the treatment of hyponatremia.
    Dasta JF, Chiong JR, Christian R, Friend K, Lingohr-Smith M, Lin J, Cassidy IB.
    Expert Rev Pharmacoecon Outcomes Res; 2012 Aug 16; 12(4):399-410. PubMed ID: 22971027
    [Abstract] [Full Text] [Related]

  • 9. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.
    Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C, SALT Investigators.
    N Engl J Med; 2006 Nov 16; 355(20):2099-112. PubMed ID: 17105757
    [Abstract] [Full Text] [Related]

  • 10. Hyponatremia in heart failure.
    Farmakis D, Filippatos G, Parissis J, Kremastinos DT, Gheorghiade M.
    Heart Fail Rev; 2009 Jun 16; 14(2):59-63. PubMed ID: 18758941
    [Abstract] [Full Text] [Related]

  • 11. Serum and urine responses to the aquaretic agent tolvaptan in hospitalized hyponatremic patients.
    Vaghasiya RP, DeVita MV, Michelis MF.
    Int Urol Nephrol; 2012 Jun 16; 44(3):865-71. PubMed ID: 21607553
    [Abstract] [Full Text] [Related]

  • 12. Clinical review: the use of vaptans in clinical endocrinology.
    Peri A.
    J Clin Endocrinol Metab; 2013 Apr 16; 98(4):1321-32. PubMed ID: 23401044
    [Abstract] [Full Text] [Related]

  • 13. Utilization and budget impact of tolvaptan in the inpatient setting among patients with heart failure and hyponatremia.
    Amin AN, Ortendahl JD, Harmon AL, Kamat SA, Stellhorn RA, Chase SL, Sundar SV.
    Curr Med Res Opin; 2018 Mar 16; 34(3):559-566. PubMed ID: 29297709
    [Abstract] [Full Text] [Related]

  • 14. [From hyponatremia to tolvaptan].
    Cernaro V, Santoro D, Lacquaniti A, Montalto G, Buemi M.
    G Ital Nefrol; 2014 Mar 16; 31(1):. PubMed ID: 24671837
    [Abstract] [Full Text] [Related]

  • 15. Effect of serum sodium concentration and tolvaptan treatment on length of hospitalization in patients with heart failure.
    Cyr PL, Slawsky KA, Olchanski N, Krasa HB, Goss TF, Zimmer C, Hauptman PJ.
    Am J Health Syst Pharm; 2011 Feb 15; 68(4):328-33. PubMed ID: 21289328
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of costs associated with tolvaptan-mediated hospital length of stay reduction among US patients with the syndrome of inappropriate antidiuretic hormone secretion, based on SALT-1 and SALT-2 trials.
    Dasta JF, Chiong JR, Christian R, Lin J.
    Hosp Pract (1995); 2012 Feb 15; 40(1):7-14. PubMed ID: 22406878
    [Abstract] [Full Text] [Related]

  • 17. Hyponatremia, heart failure, and the role of tolvaptan.
    O'Connell JB, Alemayehu A.
    Postgrad Med; 2012 Mar 15; 124(2):29-39. PubMed ID: 22437213
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of costs associated with tolvaptan-mediated length-of-stay reduction among heart failure patients with hyponatremia in the US, based on the EVEREST trial.
    Chiong JR, Kim S, Lin J, Christian R, Dasta JF.
    J Med Econ; 2012 Mar 15; 15(2):276-84. PubMed ID: 22111754
    [Abstract] [Full Text] [Related]

  • 19. Long-term low-dose tolvaptan treatment in hospitalized male patients aged >90 years with hyponatremia: Report on safety and effectiveness.
    Liu YH, Han XB, Fei YH, Xu HT.
    Medicine (Baltimore); 2017 Dec 15; 96(52):e9539. PubMed ID: 29384972
    [Abstract] [Full Text] [Related]

  • 20. Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia.
    Hayashi M, Abe K, Fujita M, Okai K, Takahashi A, Ohira H.
    Intern Med; 2018 Sep 01; 57(17):2451-2458. PubMed ID: 29607963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.